secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001104659-24-077596
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 1.02, 2.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio repurchases previously sold assets for $1.4M; shareholders approve reverse split and warrant share issuance
--------------------------------------------------------------------------------

- Company to repurchase assets from uBriGene for $1,395,138; $100K upfront, $1,295,138 deferred for 12 months with possible extensions.
- Shareholders approved issuance of up to 60,731,608 shares underlying warrants, representing over 20% of outstanding common stock.
- Shareholders also authorized a reverse stock split between 1-for-10 and 1-for-50, with Board to determine exact ratio.
- Repurchase is an Expedited Divestment under CFIUS National Security Agreement signed May 13, 2024, reversing the prior sale.
- Company may defer deferred payment if net assets fall below $20M; unpaid amounts accrue 5% interest after 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/0001104659-24-077596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/tm2418844d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-077596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer